Cordlife Group Ltd
SGX:P8A
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.12
0.455
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Cordlife Group Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | SG |
Market Cap | 39.7m SGD |
Net Margin |
-30%
|
Country | US |
Market Cap | 91.8B USD |
Net Margin |
1%
|
Country | US |
Market Cap | 87.7B EUR |
Net Margin |
1%
|
Country | US |
Market Cap | 73B USD |
Net Margin |
1%
|
Country | DE |
Market Cap | 24.9B EUR |
Net Margin |
3%
|
Country | US |
Market Cap | 20.1B USD |
Net Margin |
3%
|
Country | DE |
Market Cap | 18.8B EUR |
Net Margin |
-2%
|
Country | US |
Market Cap | 18.3B USD |
Net Margin |
9%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
7%
|
Country | DE |
Market Cap | 12.4B EUR |
Net Margin |
3%
|
Country | AU |
Market Cap | 13.4B AUD |
Net Margin |
6%
|
Cordlife Group Ltd
Glance View
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Cordlife Group Ltd's most recent financial statements, the company has Net Margin of -30.2%.